Biological E, Recbio ink pact to make HP9 vax in India
The HPV9 vaccine has been designed to protect against nine types of HPV, including those responsible for cervical, vulvar, vaginal, anal, and oropharyngeal cancers, as well as genital warts.
As part of the agreement, Recbio will provide BE with the drug substance (DS) and transfer technology to formulate, fill, and package vaccines. BE will get exclusive rights to commercialise the vaccine in India and also participate in United Nations Children's Fund (UNICEF) and Pan American Health Organisation (PAHO) tenders in other markets.
You Can Also Check:
Hyderabad AQI
|
Weather in Hyderabad
|
Bank Holidays in Hyderabad
|
Public Holidays in Hyderabad
Get the latest lifestyle updates on Times of India, along with
Doctor's Day 2025
,
messages
and quotes!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
18 hours ago
- The Hindu
Medical experts call for increased vaccination to tackle HPV-associated cancers
Medical professionals at a conclave in Coimbatore on Friday urged greater uptake of the Human Papillomavirus (HPV) vaccine to prevent cervical and other HPV-associated cancers. The awareness campaign was launched as part of a nationwide public health initiative led by the Serum Institute of India (SII). The panel comprised T.V. Chitra Bhat, Professor and Unit Head, PSG Institute of Medical Sciences and Research (PSG IMS&R); K. Aarathy, MD, Manu Hospital; P. Senthil Kumar, Senior Assistant Professor, Neonatology, Coimbatore Medical College Hospital; A. Jayavardhana, Professor and Head, PSG IMS&R and N. Jayashree, Associate Professor, Cancer Institute, Adyar. The discussion was moderated by Nandhini Kumaran, Consultant, Masonic Hospital and Sri Ramakrishna Hospital. The experts highlighted the need to raise awareness among adolescents and parents and underscored the responsibility of healthcare providers in promoting preventive care. They pointed out that although a safe and effective vaccine is available, uptake remains low in India. 'HPV is not limited to cervical cancer alone. It is also associated with cancers of the vulva, vagina, anus, penis, and oropharynx, affecting both men and women,' said Dr. Senthil Kumar. 'With peak HPV infection occurring between ages 15 and 25, early awareness and timely preventive action are essential. With the availability of Cervavac, an affordable HPV vaccine developed in India, it has become easier to protect individuals from HPV-associated cancers.' During the conclave, the panel noted that India continues to face a high burden of HPV-related diseases, with cervical cancer being the second most common cancer among women. According to the ICO/IARC Information Centre on HPV and Cancer (2023), India reports over 1.23 lakh new cervical cancer cases and more than 77,000 related deaths annually. HPV is also linked to up to 90% of anal cancers and 63% of penile cancers, they said. The experts said limited public knowledge, stigma around discussing sexually transmitted infections, and the absence of routine vaccine recommendations in clinical settings are major reasons for the low coverage.
The Hindu
a day ago
- The Hindu
Alibaba plans to raise $1.53 billion with exchangeable bonds for cloud, commerce push
Chinese tech giant Alibaba Group is seeking to raise around HK$12 billion ($1.53 billion) through exchangeable bonds to boost investments in its cloud infrastructure and global commerce operations, the company said on Thursday. Investors can later exchange these bonds, which link to Alibaba Health Technology, for shares in Alibaba Health, and the bonds will not pay interest over time. Alibaba Group holds a stake of about 64% in Alibaba Health, according to an exchange filing. The debt sale, if it goes through, follows Alibaba's $5 billion dual-currency bond in November, which was the largest deal of its kind in Asia-Pacific during 2024. Alibaba, best known for its e-commerce operations in China, has been accelerating its investments into AI, building standalone offerings around its Qwen AI models and growing its cloud services. It has also announced infrastructure investments in Thailand, Mexico and South Korea. The company's bond offering plan comes as more investors tap the Asian credit market after monetary and fiscal stimulus by Beijing policymakers improved the region's debt appeal. Chinese tech firms have previously turned to exchangeable bonds to trim their holdings, such as when Baidu raised $2 billion in March through a sale of notes exchangeable into shares of Alibaba said on Thursday it expects the Health unit to remain a flagship healthcare platform and consolidated subsidiary of Alibaba both upon the issuance and following any future exchange of bonds into Alibaba Health shares. Chinese budget retailer Miniso completed a $550 million convertible bond deal in January, choosing to use its Hong Kong-listed shares instead of its U.S.-traded American Depositary Receipts (ADRs).
The Hindu
2 days ago
- The Hindu
Letters to The Editor — July 4, 2025
A danger to democracy It is deeply shocking that the 'Special Intensive Revision of Electoral Rolls' in poll-bound Bihar is set to disenfranchise a significant percentage of voters. This massive planned pruning raises serious doubts about the intent behind the SIR. When such large-scale deletions occur without due diligence or public awareness, democracy stands threatened. Therefore, the Election Commission of India is duty bound to explain to the nation whether the SIR is a transparent cleanup or a clean-out of voters. P.H. Hema Sagar, Secunderabad The 'Tibet test' For New Delhi, it is time for a test — this time, it's the Tibet test ('World' page, July 3). With the 14th Dalai Lama explicitly asserting that his successor will be 'decided by a trust, [and] not the Chinese government', this represents yet another strategic challenge, wherein New Delhi morally needs to back the 'honoured guest'. On the other hand, such a stance may come at a strategic cost for already tricky India-China relations. The deftness with which India walks this tightrope without making compromises on strategic autonomy will determine how much India scores in the Tibet test. Nishat, New Delhi Palliative care model I write this letter as a retired professor after reading the article, 'Integrating compassion, prioritising palliative care' (Editorial page, July 3). Pallium India, Trivandrum has been successfully undertaking palliative care in India. In the family structure of the aged, having friendly carers at home remains a critical part in good palliative care. The plight of the lonely aged is what is cause for concern. Between old-age homes and family-based care, India needs mid-level aged care homes such as 'Pahal Veedu' (day care centre) for the aged. Models such as the one in Thrissur, Kerala, can be replicated across India. Dr. M.P. Boraian, Gandhigram, Tamil Nadu Rabies vaccine shortage I am writing this letter to express concern over the shortage of anti-rabies vaccines in Chennai's health centres. With rising cases of dog bites and the potential risk of rabies, there cannot be delays in treatment in the event of being bitten. There also needs to be public awareness campaigns on post-bite measures. Swetha V., Chennai
